MediSapiens Ltd

Introducing the world's most scalable and adaptable growth platform for biomedical data

General Information
Company Name
MediSapiens Ltd
Founded Year
2009
Location (Offices)
Finland +2
Founders / Decision Makers
Number of Employees
3
Industries
Biopharma, Pharmaceutical
Funding Stage
Series Unknown
Social Media

MediSapiens Ltd - Company Profile

MediSapiens Ltd is a biomedical data company founded in 2009, with a mission to revolutionize healthcare through advanced data management. The company's slogan, "Introducing the world's most scalable and adaptable growth platform for biomedical data," reflects its focus on innovation and scalability. Based in Helsinki, Finland and Cambridge, United States, MediSapiens offers the MediSapiens Genomics Suite, a cutting-edge solution that integrates genomic data into operations. The company aims to transform reactive and collective healthcare into proactive and personalized care by leveraging data effectively. For more information, visit https://medisapiens.com/ and follow @MediSapiens for updates.

Taxonomy: Genomic Data Management, Bioinformatics, Clinical Data Management, Data Analysis Software, Personalized Healthcare Solutions, Biobanking Solutions

Funding Rounds & Investors of MediSapiens Ltd (0)

View All

There is no investment information

Latest News of MediSapiens Ltd

View All

No recent news or press coverage available for MediSapiens Ltd.

Similar Companies to MediSapiens Ltd

View All
Genomics England - Similar company to MediSapiens Ltd
Genomics England We’re working to enable faster and deeper genomic diagnosis & research, to bring genomic healthcare to all who need it.
Moss Genomics - Similar company to MediSapiens Ltd
Moss Genomics Moss offers personalized health, anti-aging and wellness offerings guided by genomic, microbiome, and epigenome data
Emedgene, an Illumina Company - Similar company to MediSapiens Ltd
Emedgene, an Illumina Company Unlock genomic insights
Ovation - Similar company to MediSapiens Ltd
Ovation Ovation's mission is to unlock the potential of human genomic data to accelerate precision medicine.